Skip to main content

Table 1 Clinical and LDCT data (n = 247)

From: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19

Clinical data

All (n = 247)

Age (years)—mean ± SD

43 ± 15 [18–86]

Sex (male)

117/247 (47%)

Symptoms

230/247 (93%)

Cough

131/247 (53%)

Rhinitis

94/247 (38%)

Fever

40/247 (16%)

Anosmia

110/247 (45%)

Ageusia

102/247 (41%)

Dyspnea

68/247 (28%)

Chest pain

44/247 (18%)

Needed oxygen

7/247 (3%)

Desaturation

27/247 (11%)

Hospitalization

9/247 (4%)

Delay between first symptoms and chest CT (days)—mean ± SD

8 ± 4 [0–23]

Diabetes

12/247 (5%)

Hypertension

27/247 (11%)

Cancer status

9/247 (4%)

Cardiac disease

7/247 (3%)

LDCT data

 Dose-length product (mGy cm)—mean ± SD

39.8 ± 6.3

 Global score-mean ± SD

4.5 ± 6.5

 Normal LDCT

109/247 (44%)

 Exclusive peripheral abnormalities

98/247 (40%)

 Exclusive GGOs

102/247 (41%)

 Crazy paving pattern (GGOs + septal thickening)

16/247 (6%)

 GGOs + areas of consolidation

30/247 (12%)

  1. Clinical and LDCT data in the whole population. The qualitative variables are expressed as figures with percentages, and the continuous variables are expressed as the mean value ± DS
  2. LDCT low-dose computed tomography